查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2049486

骨關節炎治療市場報告：按解剖類型、藥物類型、給藥途徑、通路和地區分類（2026-2034 年）

Osteoarthritis Therapeutics Market Report by Anatomy Type, Drug Type, Route of Administration, Distribution Channel, and Region 2026-2034
出版日期: | 出版商: IMARC | 英文 135 Pages | 商品交期: 2-3個工作天內

價格

2025年，全球骨關節炎治療市場規模達91億美元。展望未來，IMARC Group預測，到2034年，市場規模將達到160億美元，2026年至2034年的複合年成長率為6.28%。

骨關節炎（OA）是一種以膝關節、髖關節、手關節、足關節、脊椎、肩關節和頸椎等關節軟骨進行性退化為特徵的疾病，並伴隨多種症狀。骨關節炎常見症狀包括關節僵硬、腫脹、壓痛、持續性疼痛、活動範圍受限、關節磨損、骨刺和睡眠障礙。診斷方法包括身體檢查、X光檢查、關節鏡、滑液分析、血液檢查和磁振造影（MRI）掃描。根據檢查結果，醫生會開立不同的藥物和手術方案來緩解疾病的徵兆和症狀。目前，市面上也有替代療法、物理治療和輔助器具可用於緩解疼痛和改善關節功能。

全球骨關節炎治療市場趨勢及促進因素：

久坐的生活方式、不健康的飲食習慣以及肥胖和高血糖症盛行率的上升，正在增加個體患骨關節炎的風險。加之老年人口的成長，而老年人本身也容易罹患這些疾病，這些因素共同推動了骨關節炎治療市場的成長。此外，磁振造影（MRI）掃描的普及也是市場成長的關鍵促進因素。基於X光影像觀察的影像生物標記的開發，以及鎮痛藥的引入，也促進了市場成長。同時，為研發新型診斷方法和生物標記而增加研發投入，以及改善醫療基礎設施的支出增加，也推動了市場發展。例如，目前正在研發針對促發炎細胞激素的緩解疾病藥物，用於治療軟骨退化。

目錄

第1章：序言

第2章：調查方法

  • 調查目的
  • 相關利益者
  • 數據來源
    • 主要訊息
    • 次要訊息
  • 市場估值
    • 自下而上的方法
    • 自上而下的方法
  • 預測方法

第3章執行摘要

第4章：引言

第5章：全球骨關節炎治療藥物市場

  • 市場概覽
  • 市場表現
  • 新冠疫情的影響
  • 市場預測

第6章 市場細分：依解剖類型分類

  • 膝蓋
  • 髖關節
  • 手
  • 脊椎
  • 其他

第7章 市場區隔：依藥物類型分類

  • 非類固醇消炎劑
  • 止痛藥
  • 皮質類固醇
  • 其他

第8章 市場區隔：依給藥途徑

  • 腸外
  • 外用
  • 口服

第9章 市場區隔：依分銷通路分類

  • 醫院
  • 專科診所
  • 醫療機構
  • 其他

第10章 市場區隔：依地區分類

  • 北美洲
    • 美國
    • 加拿大
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 印尼
    • 其他
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
    • 俄羅斯
    • 其他
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他
  • 中東和非洲

第11章 SWOT 分析

第12章：價值鏈分析

第13章：波特五力分析

第14章：價格分析

第15章 競爭格局

  • 市場結構
  • 大公司
  • 主要公司簡介
    • Abbott Laboratories
    • Anika Therapeutics Inc.
    • Bayer Aktiengesellschaft
    • Eli Lilly and Company
    • Flexion Therapeutics Inc.
    • GlaxoSmithKline Plc
    • Horizon Therapeutics Plc
    • Johnson & Johnson Inc.
    • Pfizer Inc.
    • Sanofi SA
Product Code: SR112026A2791

The global osteoarthritis therapeutics market size reached USD 9.1 Billion in 2025. Looking forward, IMARC Group expects the market to reach USD 16.0 Billion by 2034, exhibiting a growth rate (CAGR) of 6.28% during 2026-2034.

Osteoarthritis (OA) is a heterogeneous condition characterized by progressive degeneration of cartilage in joints of the knees, hips, hands, feet, spine, shoulders and neck. OA generally leads to stiffness, swelling, tenderness, persistent pain, loss of flexibility, grating sensation, bone spurs and sleep disturbances. It can be diagnosed using physical examination, X-ray, arthroscopy, joint fluid analysis, blood tests and magnetic resonance imaging (MRI) scan. Various medications and surgical procedures are prescribed as per the different results to alleviate the signs and symptoms of the disease. Currently, alternative medicines, physical therapies and supportive devices are available in the market to relieve pain and improve joint function.

GLOBAL OSTEOARTHRITIS THERAPEUTICS MARKET TRENDS AND DRIVERS:

Sedentary lifestyles, unhealthy dietary patterns and the rising prevalence of obesity and blood sugar are increasing the risk of developing OA among individuals. This, in confluence with the growing geriatric population, which is more susceptible to such ailments, represents one of the key factors impelling the osteoarthritis therapeutics market growth. Apart from this, the easy access to MRI scans is acting as another major growth-inducing factor. Additionally, the development of imaging biomarkers based on radiographic features, coupled with the introduction of analgesic drugs, is contributing to the market growth. Furthermore, rising investments in the research and development (R&D) activities to launch new diagnostics and biomarkers, along with the increasing expenditures on improving healthcare infrastructure, is also driving the market. For instance, disease-modifying drugs are under development, which focus on proinflammatory cytokines for treating cartilage breakdown.

KEY MARKET SEGMENTATION:

Breakup by Anatomy Type:

  • Knee
  • Hip
  • Hand
  • Spine
  • Others

Breakup by Drug Type:

  • Nonsteroidal Anti-Inflammatory Drugs
  • Analgesics
  • Corticosteroids
  • Others

Breakup by Route of Administration:

  • Parenteral
  • Topical
  • Oral

Breakup by Distribution Channel:

  • Hospitals
  • Specialty Clinics
  • Medical Institutions
  • Others

Breakup by Region:

  • North America
    • United States
    • Canada
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa

COMPETITIVE LANDSCAPE:

The report has also analysed the competitive landscape of the market with some of the key players being Abbott Laboratories, Anika Therapeutics Inc., Bayer Aktiengesellschaft, Eli Lilly and Company, Flexion Therapeutics Inc., GlaxoSmithKline Plc, Horizon Therapeutics Plc, Johnson & Johnson Inc., Pfizer Inc. and Sanofi S.A.

Key Questions Answered in This Report

1. What was the size of the global osteoarthritis therapeutics market in 2025?

2. What is the expected growth rate of the global osteoarthritis therapeutics market during 2026-2034?

3. What are the key factors driving the global osteoarthritis therapeutics market?

4. What has been the impact of COVID-19 on the global osteoarthritis therapeutics market?

5. What is the breakup of the global osteoarthritis therapeutics market based on the anatomy type?

6. What is the breakup of the global osteoarthritis therapeutics market based on the drug type?

7. What is the breakup of the global osteoarthritis therapeutics market based on the route of administration?

8. What is the breakup of the global osteoarthritis therapeutics market based on the distribution channel?

9. What are the key regions in the global osteoarthritis therapeutics market?

10. Who are the key players/companies in the global osteoarthritis therapeutics market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Osteoarthritis Therapeutics Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Anatomy Type

  • 6.1 Knee
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Hip
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Hand
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 Spine
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast
  • 6.5 Others
    • 6.5.1 Market Trends
    • 6.5.2 Market Forecast

7 Market Breakup by Drug Type

  • 7.1 Nonsteroidal Anti-Inflammatory Drugs
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Analgesics
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Corticosteroids
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Others
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast

8 Market Breakup by Route of Administration

  • 8.1 Parenteral
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Topical
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Oral
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast

9 Market Breakup by Distribution Channel

  • 9.1 Hospitals
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Specialty Clinics
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3 Medical Institutions
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast
  • 9.4 Others
    • 9.4.1 Market Trends
    • 9.4.2 Market Forecast

10 Market Breakup by Region

  • 10.1 North America
    • 10.1.1 United States
      • 10.1.1.1 Market Trends
      • 10.1.1.2 Market Forecast
    • 10.1.2 Canada
      • 10.1.2.1 Market Trends
      • 10.1.2.2 Market Forecast
  • 10.2 Asia Pacific
    • 10.2.1 China
      • 10.2.1.1 Market Trends
      • 10.2.1.2 Market Forecast
    • 10.2.2 Japan
      • 10.2.2.1 Market Trends
      • 10.2.2.2 Market Forecast
    • 10.2.3 India
      • 10.2.3.1 Market Trends
      • 10.2.3.2 Market Forecast
    • 10.2.4 South Korea
      • 10.2.4.1 Market Trends
      • 10.2.4.2 Market Forecast
    • 10.2.5 Australia
      • 10.2.5.1 Market Trends
      • 10.2.5.2 Market Forecast
    • 10.2.6 Indonesia
      • 10.2.6.1 Market Trends
      • 10.2.6.2 Market Forecast
    • 10.2.7 Others
      • 10.2.7.1 Market Trends
      • 10.2.7.2 Market Forecast
  • 10.3 Europe
    • 10.3.1 Germany
      • 10.3.1.1 Market Trends
      • 10.3.1.2 Market Forecast
    • 10.3.2 France
      • 10.3.2.1 Market Trends
      • 10.3.2.2 Market Forecast
    • 10.3.3 United Kingdom
      • 10.3.3.1 Market Trends
      • 10.3.3.2 Market Forecast
    • 10.3.4 Italy
      • 10.3.4.1 Market Trends
      • 10.3.4.2 Market Forecast
    • 10.3.5 Spain
      • 10.3.5.1 Market Trends
      • 10.3.5.2 Market Forecast
    • 10.3.6 Russia
      • 10.3.6.1 Market Trends
      • 10.3.6.2 Market Forecast
    • 10.3.7 Others
      • 10.3.7.1 Market Trends
      • 10.3.7.2 Market Forecast
  • 10.4 Latin America
    • 10.4.1 Brazil
      • 10.4.1.1 Market Trends
      • 10.4.1.2 Market Forecast
    • 10.4.2 Mexico
      • 10.4.2.1 Market Trends
      • 10.4.2.2 Market Forecast
    • 10.4.3 Others
      • 10.4.3.1 Market Trends
      • 10.4.3.2 Market Forecast
  • 10.5 Middle East and Africa
    • 10.5.1 Market Trends
    • 10.5.2 Market Breakup by Country
    • 10.5.3 Market Forecast

11 SWOT Analysis

  • 11.1 Overview
  • 11.2 Strengths
  • 11.3 Weaknesses
  • 11.4 Opportunities
  • 11.5 Threats

12 Value Chain Analysis

13 Porters Five Forces Analysis

  • 13.1 Overview
  • 13.2 Bargaining Power of Buyers
  • 13.3 Bargaining Power of Suppliers
  • 13.4 Degree of Competition
  • 13.5 Threat of New Entrants
  • 13.6 Threat of Substitutes

14 Price Analysis

15 Competitive Landscape

  • 15.1 Market Structure
  • 15.2 Key Players
  • 15.3 Profiles of Key Players
    • 15.3.1 Abbott Laboratories
      • 15.3.1.1 Company Overview
      • 15.3.1.2 Product Portfolio
      • 15.3.1.3 Financials
      • 15.3.1.4 SWOT Analysis
    • 15.3.2 Anika Therapeutics Inc.
      • 15.3.2.1 Company Overview
      • 15.3.2.2 Product Portfolio
      • 15.3.2.3 Financials
      • 15.3.2.4 SWOT Analysis
    • 15.3.3 Bayer Aktiengesellschaft
      • 15.3.3.1 Company Overview
      • 15.3.3.2 Product Portfolio
      • 15.3.3.3 Financials
      • 15.3.3.4 SWOT Analysis
    • 15.3.4 Eli Lilly and Company
      • 15.3.4.1 Company Overview
      • 15.3.4.2 Product Portfolio
      • 15.3.4.3 Financials
      • 15.3.4.4 SWOT Analysis
    • 15.3.5 Flexion Therapeutics Inc.
      • 15.3.5.1 Company Overview
      • 15.3.5.2 Product Portfolio
      • 15.3.5.3 Financials
    • 15.3.6 GlaxoSmithKline Plc
      • 15.3.6.1 Company Overview
      • 15.3.6.2 Product Portfolio
      • 15.3.6.3 Financials
      • 15.3.6.4 SWOT Analysis
    • 15.3.7 Horizon Therapeutics Plc
      • 15.3.7.1 Company Overview
      • 15.3.7.2 Product Portfolio
      • 15.3.7.3 Financials
      • 15.3.7.4 SWOT Analysis
    • 15.3.8 Johnson & Johnson Inc.
      • 15.3.8.1 Company Overview
      • 15.3.8.2 Product Portfolio
      • 15.3.8.3 Financials
      • 15.3.8.4 SWOT Analysis
    • 15.3.9 Pfizer Inc.
      • 15.3.9.1 Company Overview
      • 15.3.9.2 Product Portfolio
      • 15.3.9.3 Financials
      • 15.3.9.4 SWOT Analysis
    • 15.3.10 Sanofi S.A
      • 15.3.10.1 Company Overview
      • 15.3.10.2 Product Portfolio
      • 15.3.10.3 Financials
      • 15.3.10.4 SWOT Analysis

List of Figures

  • Figure 1: Global: Osteoarthritis Therapeutics Market: Major Drivers and Challenges
  • Figure 2: Global: Osteoarthritis Therapeutics Market: Sales Value (in Billion USD), 2020-2025
  • Figure 3: Global: Osteoarthritis Therapeutics Market: Breakup by Anatomy Type (in %), 2025
  • Figure 4: Global: Osteoarthritis Therapeutics Market: Breakup by Drug Type (in %), 2025
  • Figure 5: Global: Osteoarthritis Therapeutics Market: Breakup by Route of Administration (in %), 2025
  • Figure 6: Global: Osteoarthritis Therapeutics Market: Breakup by Distribution Channel (in %), 2025
  • Figure 7: Global: Osteoarthritis Therapeutics Market: Breakup by Region (in %), 2025
  • Figure 8: Global: Osteoarthritis Therapeutics Market Forecast: Sales Value (in Billion USD), 2026-2034
  • Figure 9: Global: Osteoarthritis Therapeutics (Knee) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 10: Global: Osteoarthritis Therapeutics (Knee) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 11: Global: Osteoarthritis Therapeutics (Hip) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 12: Global: Osteoarthritis Therapeutics (Hand) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 13: Global: Osteoarthritis Therapeutics (Hand) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 14: Global: Osteoarthritis Therapeutics (Spine) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 15: Global: Osteoarthritis Therapeutics (Spine) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 16: Global: Osteoarthritis Therapeutics (Other Anatomy Types) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 17: Global: Osteoarthritis Therapeutics (Other Anatomy Types) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 18: Global: Osteoarthritis Therapeutics (Nonsteroidal Anti-Inflammatory Drugs) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 19: Global: Osteoarthritis Therapeutics (Nonsteroidal Anti-Inflammatory Drugs) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 20: Global: Osteoarthritis Therapeutics (Analgesics) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 21: Global: Osteoarthritis Therapeutics (Analgesics) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 22: Global: Osteoarthritis Therapeutics (Corticosteroids) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 23: Global: Osteoarthritis Therapeutics (Corticosteroids) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 24: Global: Osteoarthritis Therapeutics (Other Drug Types) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 25: Global: Osteoarthritis Therapeutics (Other Drug Types) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 26: Global: Osteoarthritis Therapeutics (Parenteral) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 27: Global: Osteoarthritis Therapeutics (Parenteral) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 28: Global: Osteoarthritis Therapeutics (Topical) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 29: Global: Osteoarthritis Therapeutics (Topical) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 30: Global: Osteoarthritis Therapeutics (Oral) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 31: Global: Osteoarthritis Therapeutics (Oral) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 32: Global: Osteoarthritis Therapeutics (Hospitals) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 33: Global: Osteoarthritis Therapeutics (Hospitals) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 34: Global: Osteoarthritis Therapeutics (Specialty Clinics) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 35: Global: Osteoarthritis Therapeutics (Specialty Clinics) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 36: Global: Osteoarthritis Therapeutics (Medical Institutions) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 37: Global: Osteoarthritis Therapeutics (Medical Institutions) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 38: Global: Osteoarthritis Therapeutics (Other Distribution Channels) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 39: Global: Osteoarthritis Therapeutics (Other Distribution Channels) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 40: North America: Osteoarthritis Therapeutics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 41: North America: Osteoarthritis Therapeutics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 42: United States: Osteoarthritis Therapeutics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 43: United States: Osteoarthritis Therapeutics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 44: Canada: Osteoarthritis Therapeutics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 45: Canada: Osteoarthritis Therapeutics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 46: Asia Pacific: Osteoarthritis Therapeutics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 47: Asia Pacific: Osteoarthritis Therapeutics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 48: China: Osteoarthritis Therapeutics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 49: China: Osteoarthritis Therapeutics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 50: Japan: Osteoarthritis Therapeutics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 51: Japan: Osteoarthritis Therapeutics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 52: India: Osteoarthritis Therapeutics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 53: India: Osteoarthritis Therapeutics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 54: South Korea: Osteoarthritis Therapeutics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 55: South Korea: Osteoarthritis Therapeutics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 56: Australia: Osteoarthritis Therapeutics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 57: Australia: Osteoarthritis Therapeutics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 58: Indonesia: Osteoarthritis Therapeutics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 59: Indonesia: Osteoarthritis Therapeutics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 60: Others: Osteoarthritis Therapeutics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 61: Others: Osteoarthritis Therapeutics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 62: Europe: Osteoarthritis Therapeutics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 63: Europe: Osteoarthritis Therapeutics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 64: Germany: Osteoarthritis Therapeutics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 65: Germany: Osteoarthritis Therapeutics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 66: France: Osteoarthritis Therapeutics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 67: France: Osteoarthritis Therapeutics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 68: United Kingdom: Osteoarthritis Therapeutics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 69: United Kingdom: Osteoarthritis Therapeutics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 70: Italy: Osteoarthritis Therapeutics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 71: Italy: Osteoarthritis Therapeutics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 72: Spain: Osteoarthritis Therapeutics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 73: Spain: Osteoarthritis Therapeutics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 74: Russia: Osteoarthritis Therapeutics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 75: Russia: Osteoarthritis Therapeutics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 76: Others: Osteoarthritis Therapeutics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 77: Others: Osteoarthritis Therapeutics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 78: Latin America: Osteoarthritis Therapeutics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 79: Latin America: Osteoarthritis Therapeutics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 80: Brazil: Osteoarthritis Therapeutics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 81: Brazil: Osteoarthritis Therapeutics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 82: Mexico: Osteoarthritis Therapeutics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 83: Mexico: Osteoarthritis Therapeutics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 84: Others: Osteoarthritis Therapeutics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 85: Others: Osteoarthritis Therapeutics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 86: Middle East and Africa: Osteoarthritis Therapeutics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 87: Middle East and Africa: Osteoarthritis Therapeutics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 88: Global: Osteoarthritis Therapeutics Industry: SWOT Analysis
  • Figure 89: Global: Osteoarthritis Therapeutics Industry: Value Chain Analysis
  • Figure 90: Global: Osteoarthritis Therapeutics Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Osteoarthritis Therapeutics Market: Key Industry Highlights, 2025 and 2034
  • Table 2: Global: Osteoarthritis Therapeutics Market Forecast: Breakup by Anatomy Type (in Million USD), 2026-2034
  • Table 3: Global: Osteoarthritis Therapeutics Market Forecast: Breakup by Drug Type (in Million USD), 2026-2034
  • Table 4: Global: Osteoarthritis Therapeutics Market Forecast: Breakup by Route of Administration (in Million USD), 2026-2034
  • Table 5: Global: Osteoarthritis Therapeutics Market Forecast: Breakup by Distribution Channel (in Million USD), 2026-2034
  • Table 6: Global: Osteoarthritis Therapeutics Market Forecast: Breakup by Region (in Million USD), 2026-2034
  • Table 7: Global: Osteoarthritis Therapeutics Market: Competitive Structure
  • Table 8: Global: Osteoarthritis Therapeutics Market: Key Players